SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-14-394981
Filing Date
2014-11-04
Accepted
2014-11-04 06:05:26
Documents
4
Period of Report
2014-10-30
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d814490d8k.htm 8-K 15376
2 EX-10.1 d814490dex101.htm EX-10.1 48336
3 GRAPHIC g814490g27m02.jpg GRAPHIC 90286
4 GRAPHIC g814490g76u38.jpg GRAPHIC 53974
  Complete submission text file 0001193125-14-394981.txt   263905
Mailing Address 1035 O?BRIEN DRIVE, SUITE A MENLO PARK CA 94025
Business Address 1035 O?BRIEN DRIVE, SUITE A MENLO PARK CA 94025 650-272-6269
Avalanche Biotechnologies, Inc. (Filer) CIK: 0001501756 (see all company filings)

IRS No.: 205258327 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36579 | Film No.: 141190979
SIC: 2836 Biological Products, (No Diagnostic Substances)